Order Article Reprints

Pourtau L, Wauquier F, Boutin-Wittrant L, Gaudout D, Moras B, Vignault A, Vaysse C, Richard T, Courtois A, Krisa S, et al. Reduced Production of Pro-Inflammatory and Pro-Catabolic Factors by Human Serum Metabolites Derived from a Patented Saffron Extract Intake. Pharmaceutics. 2024; 16(3):336. https://doi.org/10.3390/pharmaceutics16030336

Pourtau, Line, Fabien Wauquier, Line Boutin-Wittrant, David Gaudout, Benjamin Moras, Adeline Vignault, Carole Vaysse, Tristan Richard, Arnaud Courtois, Stéphanie Krisa, and et al. 2024. "Reduced Production of Pro-Inflammatory and Pro-Catabolic Factors by Human Serum Metabolites Derived from a Patented Saffron Extract Intake" Pharmaceutics 16, no. 3: 336. https://doi.org/10.3390/pharmaceutics16030336

Pourtau, L., Wauquier, F., Boutin-Wittrant, L., Gaudout, D., Moras, B., Vignault, A., Vaysse, C., Richard, T., Courtois, A., Krisa, S., Roux, V., Macian, N., Pickering, G., & Wittrant, Y. (2024). Reduced Production of Pro-Inflammatory and Pro-Catabolic Factors by Human Serum Metabolites Derived from a Patented Saffron Extract Intake. Pharmaceutics, 16(3), 336. https://doi.org/10.3390/pharmaceutics16030336